STK3 and melanoma: We have previously shown that MST2 mediates a proapoptotic signal that is inhibited by RAF kinases (O’Neill et al, 2004) and were interested in studying the possible role of the MST2 pathway in the response to RAFi used in the clinic to treat melanoma.